| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.3 | 0.003 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.004 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |